International Steering Committee

The International Steering Committee (ISC) provides overall strategy on the evolution of ICAV.

Dr. Ralf Altmeyer
CEO, CombinatoRx, Singapore

Dr. Bruno Canard
Research Director, VIZIER/AFMB, Marseilles, France

Dr. Jeremy Carver
CEO/CSO & Co-founder, ICAV, Canada

Dr. Michel Chrétien
Director of International Partnerships & Co-founder ICAV, Canada

Dr. Erik de Clercq
Faculty of Medicine, Rega Institute, Leuven, Belgium

Dr. George Fu Gao
Senior Scientist, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China

Dr. Rolf Hilgenfeld
Director, Institute of Biochemistry, University of Lübeck, Germany

Dr. Hans-Dieter Klenk
Institute of Virology, University of Marburg, Germany

Dr. Albert Osterhaus
Head, Department of Virology, Erasmus University, Netherlands

Sir John Skehel
Former Director of the MRC-NIMR, Mill Hill, UK

Professor Oyewale Tomori
Vice Chancellor, Redeemer’s University, Nigeria

Dr. Noël Tordo
Unit Antiviral Strategies, Virology Department, Institut Pasteur, France

Dr. Igor Tvaroska
Director, Institute of Chemistry, Slovak Academy of Sciences, Slovakia

Dr. Mark von Itzstein
Director, Institute for Glycomics, Griffith University, Australia

Dr. Andrew Wang
Vice President, Academica Sinica, Taiwan